Abstract | BACKGROUND & AIMS: N-linked glycosylation of proteins is critical for proper protein folding and trafficking to the plasma membrane. Drug transporters are one class of proteins that have reduced function when glycosylation is impaired. N-linked glycosylation of plasma proteins has also been investigated as a biomarker for several liver diseases, including non-alcoholic fatty liver disease ( NAFLD). The purpose of this study was to assess the transcriptomic expression of genes involved in protein processing and glycosylation, and to determine the glycosylation status of key drug transporters during human NAFLD progression. METHODS: Human liver samples diagnosed as healthy, steatosis, and non- alcoholic steatohepatitis (NASH) were analysed for gene expression of glycosylation-related genes and for protein glycosylation using immunoblot. RESULTS: CONCLUSIONS: These data suggest that the loss of glycosylation of key uptake and efflux transporters in humans NASH may influence transporter function and contribute to altered drug disposition observed in NASH.
|
Authors | John D Clarke, Petr Novak, April D Lake, Rhiannon N Hardwick, Nathan J Cherrington |
Journal | Liver international : official journal of the International Association for the Study of the Liver
(Liver Int)
Vol. 37
Issue 7
Pg. 1074-1081
(07 2017)
ISSN: 1478-3231 [Electronic] United States |
PMID | 28097795
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Chemical References |
- Membrane Transport Proteins
|
Topics |
- Biological Transport
- Blotting, Western
- Case-Control Studies
- Endoplasmic Reticulum
(metabolism)
- Gene Expression Profiling
- Glycosylation
- Humans
- Liver
(metabolism)
- Membrane Transport Proteins
(genetics, metabolism)
- Non-alcoholic Fatty Liver Disease
(diagnosis, genetics, metabolism)
- Protein Processing, Post-Translational
- Transcriptome
|